Literature DB >> 2041671

Eradication of poliomyelitis: progress in the Americas.

C A De Quadros1, J K Andrus, J M Olivé, C M Da Silveira, R M Eikhof, P Carrasco, J W Fitzsimmons, F P Pinheiro.   

Abstract

In the span of 5 years since the eradication initiative was launched and only 3 years since external funds were made available, PAHO has been able to develop and implement a comprehensive program strategy for polio eradication that includes the following components: achievement and maintenance of high immunization levels (which include the supplemental strategies of national immunization days and mop-up operations); effective surveillance to detect all new cases; and a rapid response to the occurrence of new cases. Despite yearly increases in the number of cases of acute flaccid paralysis reported to the surveillance system, a decline in reported confirmed cases of polio has occurred since 1986 to record low levels in 1989. Cases in 1989 were reported from only 0.7% of the counties in the Americas. The occurrence of 24 wild-type virus isolates in 1989 were limited to only three geographic areas: northwestern Mexico; the northern Andean Region; and northeastern Brazil. At this writing the clock is ticking with only 3 months left to achieve the goal of interrupting transmission by the end of 1990. If the current level of effort is sustained and special efforts are directed at the remaining foci of infection, the eradication of the transmission of wild-type poliovirus from the Americas can be achieved. Continued external financial support will be critical if the effort is to succeed. The prospect of poliomyelitis eradication in the Americas led the 41st World Health Assembly of WHO to adopt a resolution in May, 1988, to eradicate the indigenous transmission of wild-type poliovirus from the world by the year 2000.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2041671     DOI: 10.1097/00006454-199103000-00011

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  19 in total

Review 1.  Poliomyelitis: eradication in sight.

Authors:  J L Melnick
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

2.  Can we capitalize on the virtues of vaccines? Insights from the polio eradication initiative.

Authors:  R Bruce Aylward; David L Heymann
Journal:  Am J Public Health       Date:  2005-05       Impact factor: 9.308

3.  The risks, costs, and benefits of possible future global policies for managing polioviruses.

Authors:  Kimberly M Thompson; Radboud J Duintjer Tebbens; Mark A Pallansch; Olen M Kew; Roland W Sutter; R Bruce Aylward; Margaret Watkins; Howard E Gary; James Alexander; Hamid Jafari; Stephen L Cochi
Journal:  Am J Public Health       Date:  2008-05-29       Impact factor: 9.308

4.  Comment: ethical dilemmas in worldwide polio eradication programs.

Authors:  R W Sutter; S L Cochi
Journal:  Am J Public Health       Date:  1997-06       Impact factor: 9.308

5.  Application of the polymerase chain reaction (PCR) to poliomyelitis surveillance through the analyses of sewage samples.

Authors:  E Marques; E E Da Silva; V M Dos Santos; O M Kew; M T Martins
Journal:  World J Microbiol Biotechnol       Date:  1993-09       Impact factor: 3.312

6.  Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.

Authors:  P Mas Lago; J Ramon Bravo; J K Andrus; M M Comellas; M A Galindo; C A de Quadros; E Bell
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

7.  Surveillance for the Expanded Programme on Immunization.

Authors:  F T Cutts; R J Waldman; H M Zoffman
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

8.  Serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population in Kenya.

Authors:  P W Kok; J Leeuwenburg; P Tukei; A L van Wezel; J G Kapsenberg; G van Steenis; A Galazka; S E Robertson; D Robinson
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

9.  Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91.

Authors:  J K Andrus; P M Strebel; C A de Quadros; J M Olivé
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

10.  Evaluation of house-to-house versus fixed-site oral poliovirus vaccine delivery strategies in a mass immunization campaign in Egypt.

Authors:  R W Linkins; E Mansour; O Wassif; M H Hassan; P A Patriarca
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.